ID
Idorsia Ltd
IDRSF · OTC
$6.13 +0.00% (+$0.00)
1M -5.69%
Market Cap CHF 1.28B
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
21 /100
Expensive P/S 6.43x
PEG N/A
P/E N/A
Growth
100 /100
Growing Rev. growth 31.56%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 79.80%
Gross margin 78.89%
FCF margin 65.28%
Quality
8 /100
Poor Asset turnover 0.43x
ROIC 47.82%
ROA 68.28%
Debt
6 /100
High Int. coverage 0.18x
Current ratio 0.58x
Debt/Assets N/A
Stability
26 /100
Unstable EPS volatility 29.45%
Beta 1.66x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre IDRSF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jean-Paul Clozel
Employees
487
Headquarters
Allschwil
Evenimente viitoare
29 OCT.
Earnings
Upcoming earnings report